Precigen
PGEN
#5013
Rank
HK$15.09 B
Marketcap
HK$42.34
Share price
-2.53%
Change (1 day)
241.42%
Change (1 year)

Earnings for Precigen (PGEN)

Earnings in 2026 (TTM): -HK$1.6 Billion

According to Precigen's latest financial reports the company's current earnings are HK$31.59 Million. In 2025 the company made an earning of -HK$1.97 Billion a decrease over its 2024 earnings that were of -HK$1.01 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Precigen from 2012 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -HK$1.6 Billion-18.95%
2025 -HK$1.97 Billion95.77%
2024 -HK$1.01 Billion32.86%
2023 -HK$0.76 Billion20.5%
2022 -HK$0.63 Billion-23.33%
2021 -HK$0.82 Billion60.11%
2020 -HK$0.52 Billion-65.1%
2019 -HK$1.47 Billion-65.19%
2018 -HK$4.21 Billion313.44%
2017 -HK$1.02 Billion-33.2%
2016 -HK$1.53 Billion123.22%
2015 -HK$0.69 Billion1.47%
2014 -HK$0.68 Billion109.54%
2013 -HK$0.33 Billion-50.04%
2012 -HK$0.65 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Organovo
ONVO
-HK$19.5 Million-98.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-HK$0.58 Billion-64.26%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
-HK$0.51 Billion-68.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-HK$1.17 Billion-27.22% Jersey